Click here to search courses using NAPNAP's previous Course Catalog layout.

Title
Category
Credits
Event date
Cost
  • Primary Care
  • Acute Care
  • Pharmacology CE
  • Contact hours
$25.00
1.25 NAPNAP Contact Hour, 0.5 Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is 12.5$ for NAPNAP Members. For non- members, this continuing education activity rate is 25$. Cough, both acute and chronic, is one of the most common complaints in the primary and acute care settings. Cough can be stressful and instigate fear and sleepless nights for both children and parents. Early and accurate diagnosis, as well as appropriate therapeutic management, is imperative. This presentation will guide the pediatric focused provider in decision making when diagnosing chronic cough as well as provide a review of current diagnostic testing recommendations and pharmacological updates.
  • Primary Care
  • Acute Care
  • Contact hours
$20.00
1.00 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members for $10 and $20 for non-members. This course will discuss discuss common mechanisms of injury in pediatric trauma and likely subsequent injuries, review subtle signs and symptoms that may be overlooked, and describe potential complications of missed injuries
  • Acute Care
  • Contact hours
$20.00
1.0 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is 10$ for NAPNAP Members. For non- members, this continuing education activity rate is 20$. Pediatric-focused nurse practitioners in the PICU provide care for chronically, critically ill children every day. With the advancement of technology, many of these children are surviving and even thriving. However, ethical conflict can sometimes arise between providers and caregivers when these children become critically ill. Providers must then discuss and merge these conflicts while keeping the best interests of the child in mind. The presenter will review an ethical principles and discuss relevant cases studies, providing in-depth discussion regarding strategies to providing compassionate, ethical care in the PICU for these critically ill children.
  • Primary Care
  • Acute Care
  • Contact hours
$25.00
1.25 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is 12.5$ for NAPNAP Members. For non- members, this continuing education activity rate is 25$. This presentation will describe the steps of pediatric GU exam, list normal vs. concerning GU variants, and define treatment recommendations and guidelines for pediatric victims of sexual assault.
  • Acute Care
  • Pharmacology CE
  • Contact hours
$30.00
1.5 NAPNAP Contact Hour, 0.5 Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is 15$ for NAPNAP Members. For non- members, this continuing education activity rate is 30$. Jennifer Joiner is a dual certified pediatric nurse practitioner who serves as the inpatient nurse practitioner for The Children’s Heart Center at the Children’s Hospital of San Antonio for Baylor College of Medicine. Jen has had the privilege of taking care of almost every population of patient in critical care and has been a preceptor and lead of several advanced practice groups. She served as an original test item writer for the PNCB's pilot exam in Acute Care in 2004 and assisted the PNCB by writing acute care pediatric updates for many years.
  • Primary Care
  • Acute Care
  • Immunization
  • Contact hours
$20.00
0.5 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is 10$ for NAPNAP Members. For non- members, this continuing education activity rate is 20$. This educational activity is sponsored by The Immunization Special Interest Group (IMM SIG). This module on preventing immunization associated pain is designed to help providers utilize and identify age appropriate pain prevention techniques and explain how these techniques work. After this module, providers will be able to teach patients and families about pain prevention during immunizations. All healthcare providers can utilize the information and skills taught in this module.
  • Primary Care
  • Acute Care
  • Human Trafficking
  • Contact hours
$20.00
1.0 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is 10$ for NAPNAP Members. For non- members, this continuing education activity rate is 20$. 3-PARRT (Providers Assessing Risk and Responding to Trafficking) - Up to 87 percent of human trafficking victims have encountered a healthcare professional without being identified. Now is your chance to learn about human trafficking, especially related to children, adolescents and teens, so you are ready to help a victim in your practice setting. Don’t be fooled – trafficking happens in every state and every community. Human Trafficking 101, educates participants about this $32 billion criminal industry and its prevalence in all communities and sectors of our society. Participants will also learn how to recognize the signs of human trafficking in child victims and understand situations and challenges that make kids susceptible to trafficking predators.
  • Acute Care
  • Pharmacology CE
  • Controlled Substances CE
  • Contact hours
$20.00
1.0 NAPNAP Pharmacology Contact Hour, 1.0 controlled substance . This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is 10$ for NAPNAP Members. For non- members, this continuing education activity rate is 20$. The opioid epidemic brought to light the extent of opioid use across America. Among hospitalized children, 40% receive an opioid prescription. While acute pain management is essential to hospital care and opioids are a mainstay of treatment, children who receive an opioid prescription have a greater risk of develop opioid use disorder. This presentation will cover the latest evidence-based recommendations for opioid use in management of acute pain, including the first-ever pediatric-focused recommendations. Attendees will have exposure to controlled substance education necessary for ongoing APRN licensure and prescriptive authority.
  • Acute Care
  • Contact hours
$20.00
1.0 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is 10$ for NAPNAP Members. For non- members, this continuing education activity rate is 20$. The hand is one of the most frequently injured parts of a child's body, accounting for approximately 15% of pediatric fractures and 2.3% of all pediatric emergency room visits. Early recognition along with appropriate and timely management of these injuries is necessary in order to prevent potential functional deficits or cosmetic deformities. The presenter will provide clinical pearls for evaluating pediatric/adolescent hand injuries and review current treatment recommendations for both definitive care as well as initial management in the primary care and acute care emergency room settings.
  • Primary Care
  • Acute Care
  • Pharmacology CE
$145.00
8.25 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $65 for NAPNAP Members. For non- members, this continuing education activity rate is $145. Current pediatric prescribing recommendations will be reviewed. An extensive review and update will provide the participant with an improved understanding of therapeutic benefits, as well as potential risks of medications prescribed for children, including efficacy, safety and prescribing recommendations. Drugs abused by adolescents, nutraceuticals used with children, updates on treatment guidelines and changes in drug labeling, as well as dermatology will be also reviewed.

Pages